author-photo

Mia Aaboe Jørgensen

Copenhagen University Hospital

7

Papers

46

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.

2021 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

2020 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (6)
Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

2019 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (2)
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope.

2019 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (3)
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (12)
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

2018 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (22)